Position in HRMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,713,431
-$2,165,379 QoQ
Shares Held
733,684
-28.8% QoQ
Ownership
1.26%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 328 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 61%
Shared 0%
None 39%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,847,277 across 523 Biotechnology names. HRMY ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in HRMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,713,431 | 733,684 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $28,878,810 | 1,031,018 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $30,591,107 | 817,507 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $23,367,982 | 847,895 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $23,980,067 | 758,863 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $21,776,088 | 656,104 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $27,764,841 | 806,883 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $34,027,120 | 850,678 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $25,225,464 | 836,111 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $29,729,881 | 885,345 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $35,084,741 | 1,086,215 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $24,755,930 | 755,445 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $25,689,541 | 730,024 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $18,351,647 | 562,072 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $21,837,008 | 396,316 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,296,011 | 322,782 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,411,268 | 213,477 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $7,860,573 | 161,574 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $7,296,000 | 171,107 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,705,069 | 44,484 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,634,780 | 128,756 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,108,844 | 63,827 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $754,305 | 20,866 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,695 | 50 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||